Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.59
-0.06-3.64%
At close: -
$1.57
-0.02-1.25%
After Hours: 4:34 PM EDT
Comments
Loading...
Metagenomi (MGX) Forecast
NewsEarningsMetagenomi (MGX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Metagenomi Stock Price, Quotes and Forecasts | NASDAQ:MGX | Benzinga
Explore Metagenomi stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MGX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Metagenomi (MGX) stock?
You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.
Who are Metagenomi (MGX) competitors?
Other companies in Metagenomi’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX), Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR) and Immuneering (NASDAQ:IMRX).
What is the forecast, or price target, for Metagenomi (MGX) stock?
Metagenomi has a consensus price target of $15.83.
What is the current price for Metagenomi (MGX)?
The stock price for Metagenomi (NASDAQ: MGX) is $1.5701 last updated March 25, 2025 at 4:34 PM EDT.
Does Metagenomi (MGX) pay a dividend?
There are no upcoming dividends for Metagenomi.
When is Metagenomi (NASDAQ:MGX) reporting earnings?
Metagenomi’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Metagenomi (MGX) going to split?
There is no upcoming split for Metagenomi.
What sector and industry does Metagenomi (MGX) operate in?
Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.